SI9011744B - New esters of carboxylic acid with amino-alcohols, their quaternary products and the preparation and application of these compounds - Google Patents

New esters of carboxylic acid with amino-alcohols, their quaternary products and the preparation and application of these compounds Download PDF

Info

Publication number
SI9011744B
SI9011744B SI9011744A SI9011744A SI9011744B SI 9011744 B SI9011744 B SI 9011744B SI 9011744 A SI9011744 A SI 9011744A SI 9011744 A SI9011744 A SI 9011744A SI 9011744 B SI9011744 B SI 9011744B
Authority
SI
Slovenia
Prior art keywords
stands
compounds
compounds according
thienyl
residue
Prior art date
Application number
SI9011744A
Other languages
Slovenian (sl)
Other versions
SI9011744A (en
Inventor
Rolf Banholzer
Rudolf Bauer
Richard Reichl
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6389619&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI9011744(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of SI9011744A publication Critical patent/SI9011744A/en
Publication of SI9011744B publication Critical patent/SI9011744B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/14Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06Oxygen atoms
    • C07D451/10Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Disintegrating Or Milling (AREA)
  • Glass Compositions (AREA)
  • Compositions Of Oxide Ceramics (AREA)

Abstract

The new compounds of formula (I) (where A, R1, Ra and R2 are defined in the description) can be manufactured by processes known per se and used as the active ingredients of drugs.

Claims (6)

PATENTNI ZAHTEVKI l.Spojine R (I), R-,-Č-CO-OA K v kateri A stoji za skupinoClaims 1 Compounds R (I), R -, - Č-CO-OA K in which A stands for group &lt;CH2&gt;m-CH -CH Q'&lt; CH2 &gt; m-CH -CH Q ' (cH2)n-CH (II) v kateri m in n neodvisno drug od drugega pomenita 1 j Q eno izmed dvoveznih skupin -CH2-CH2-, -CH2-CH2-CH2-, -CH=CH-, in(cH2) n-CH (II) in which m and n independently of one another Q 1 represent one of the double bonds -CH 2 -CH 2 -, -CH 2 -CH 2 -CH 2 -, -CH = CH-, and JI Q’ predstavlja skupino = NR ali skupino = NRR’, pri Čemer R pomeni H ali v danem primeru s halogenom ali hidroksi substituiran Ct-C4 alkilni ostanek, R’ pa Cj-C4 -alkilni ostanek in R in R’ lahko skupaj tvorita tudi C4-C6 -alkilenski ostanek in pri čemer pri kvartemih spojinah stoji nasproti pozitivnega naboja N-atoma ekvivalent aniona (X®), Rj stoji za tienilni, fenilni, furilni, ciklopentilni ali cikloheksilni ostanek, pri čemer so ti ostanki lahko tudi substituirani z metilom, tienil in fenil pa tudi s fluorom ali klorom, R^ stoji za vodik, OH, C1-C4 - alkoksi ali Cj-C^- alkil, Ra stoji za H, F, C1 ali CHj.JI Q 'represents a group = NR or a group = NRR', wherein R is H or optionally a halogen or hydroxy substituted C1-C4 alkyl radical, and R 'is a C1-C4 alkyl radical and R and R' may together form also a C4-C6-alkylene residue and wherein in the case of quaternary compounds there is an anion equivalent (X®) opposite the positive charge of the N-atom, R 1 is a thienyl, phenyl, furyl, cyclopentyl or cyclohexyl residue, these residues may also be substituted by methyl, thienyl and phenyl as well as fluorine or chlorine, R 1 represents hydrogen, OH, C 1 -C 4 -alkoxy or C 1 -C 4 -alkyl, Ra represents H, F, C 1 or CH 2. 2. Spojine po zahtevku 1, kjer Rx stoji za 2-tienil.Compounds according to claim 1, wherein Rx is 2-thienyl. 3. Spojine po zahtevku 1 ali 2, kjer R2 stoji za OH.Compounds according to claim 1 or 2, wherein R 2 stands for OH. 4. Spojine po zahtevku 1, 2 ali 3, kjer A stoji zaCompounds according to claim 1, 2 or 3, wherein A stands for RNR·®RNR · ® z kjer imata R in X°zgornji pomen ter ima R’ zgornji pomen z izjemo vodika.z wherein R and X ° have the upper meaning and R 'has the upper meaning with the exception of hydrogen. 5. Spojine po zahtevku 1-4, kjer Ra pomeni 2-tienil in A stoji za ostanek aliCompounds according to claims 1-4, wherein Ra represents 2-thienyl and A stands for a residue or v oblik’ 3a, kjer je X® ekvivalent aniona, prednostno Br®ali CH^SO^to form '3a, wherein X® is the equivalent of an anion, preferably Br® or CH 2 SO 2 6. Postopek za pripravo spojin po zahtevkih 1 do 5 ali 7, označen s tem, da ester s formulo R a S (IV) , R^C-CO-OR R 3 2 v kateri R” stoji za Cj-C4-alkilni ostanek, in imajo Rr R2 in Ra zgornji pomen, preestrimo z aminoalkoholom s formulo (V) HO-CH (CH2)n-CH v kateri imajo m, n in Q zgornji pomen in Q” stoji za =NR ali za =NH,v inertnem organskem topilu ali v talini v prisotnosti katalizatorja za preestrenje ter dobljeno spojino v danem primeru a) če Q” pomeni =NR (pri čemer je R različen od vodika), kvatemiramo z mono derivatom Z-^-Oj-alkil) ustreznega alkana sposobnim za reakcijo (Z = odcepljiva skupina), ali b) če Q” pomeni =NH, substituiramo in kvatemiramo s terminalnim alkanom Z-(C4-C6-alkilen)-Z, brez vmesnega izoliranja. kProcess for the preparation of compounds according to Claims 1 to 5 or 7, characterized in that the ester of the formula R a S (IV), R 1 -C-CO-OR R 3 2 in which R 1 stands for C 1 -C 4 -alkyl the residue, and Rr R2 and Ra have the above meaning, are esterified with an amino alcohol of formula (V) HO-CH (CH2) n-CH in which m, n and Q have the above meaning and Q ”stands for = NR or for = NH, in an inert organic solvent or in a melt in the presence of a transesterification catalyst and the resulting compound optionally a) if Q 'is = NR (wherein R is other than hydrogen), quaterified with a mono derivative of Z - C 1 -C 10 alkyl) of the corresponding alkane reactive (Z = leaving group), or b) if Q 'is = NH, is substituted and quaternary with the terminal alkane Z- (C4-C6-alkylene) -Z, without intermediate isolation. k v obliki 3a kot njihovi metobromidi ali metometansulfonati. Za: BOERINGERINGELHEIM KG PATENTNA PISARNA, d.o.o. LAi PIJANA. ČOPOVA 14 ΡΛ bin the form of 3a as their metobromides or metomethanesulfonates. For: BOERINGERINGELHEIM KG PATENTNA PISARNA, d.o.o. LAI PIJANA. ČOPOVA 14 ΡΛ b
SI9011744A 1989-09-16 1990-09-13 New esters of carboxylic acid with amino-alcohols, their quaternary products and the preparation and application of these compounds SI9011744B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3931041A DE3931041C2 (en) 1989-09-16 1989-09-16 Esters of thienyl carboxylic acids with amino alcohols, their quaternization products, processes for their preparation and medicaments containing them
YU174490A YU47800B (en) 1989-09-16 1990-09-13 THIENYL-CARBOXYLIC ACIDS WITH AMINO-ALCOHOLS, THEIR QUANTITATIVE COMPOUNDS AND THE PREPARATION OF THESE COMPOUNDS

Publications (2)

Publication Number Publication Date
SI9011744A SI9011744A (en) 1997-10-31
SI9011744B true SI9011744B (en) 1999-12-31

Family

ID=6389619

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9011744A SI9011744B (en) 1989-09-16 1990-09-13 New esters of carboxylic acid with amino-alcohols, their quaternary products and the preparation and application of these compounds

Country Status (33)

Country Link
US (1) USRE39820E1 (en)
EP (1) EP0418716B1 (en)
JP (1) JPH0730074B2 (en)
KR (1) KR0168432B1 (en)
AT (1) ATE103914T1 (en)
AU (1) AU642913B2 (en)
BG (1) BG61295B2 (en)
CA (1) CA2066248C (en)
CZ (1) CZ284589B6 (en)
DD (1) DD297647A5 (en)
DE (3) DE3931041C2 (en)
DK (1) DK0418716T3 (en)
ES (1) ES2052125T3 (en)
FI (1) FI114395B (en)
HR (1) HRP940723B1 (en)
HU (2) HU208823B (en)
IE (1) IE65528B1 (en)
IL (1) IL95691A (en)
LU (1) LU90949I2 (en)
MX (1) MX9203150A (en)
NL (1) NL300084I2 (en)
NO (2) NO301478B1 (en)
NZ (1) NZ235306A (en)
PH (1) PH31617A (en)
PL (1) PL168468B1 (en)
PT (1) PT95312B (en)
RU (1) RU2073677C1 (en)
SI (1) SI9011744B (en)
SK (1) SK452390A3 (en)
UA (1) UA41272C2 (en)
WO (1) WO1991004252A1 (en)
YU (1) YU47800B (en)
ZA (1) ZA907338B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6777423B2 (en) * 2000-10-12 2004-08-17 Boehringer Ingelheim Pharma Kg Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
US7244415B2 (en) 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
US7879871B2 (en) 2005-05-02 2011-02-01 Boehringer Ingelheim International Gmbh Crystalline forms of tiotropium bromide

Families Citing this family (146)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (en) 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Esters of thienyl carboxylic acids with amino alcohols, their quaternization products, processes for their preparation and medicaments containing them
DE4108393A1 (en) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg NEW ESTERS BI-AND TRICYCLIC AMINO ALCOHOLS, THEIR PREPARATION AND THEIR USE IN MEDICINAL PRODUCTS
US5770738A (en) * 1992-03-05 1998-06-23 Boehringer Ingelheim Kg Esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions
DE19921693A1 (en) 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Pharmaceutical composition for treating respiratory disorders, e.g. asthma, comprises combination of anticholinergic and beta-mimetic agents having synergistic bronchospasmolytic activity and reduced side-effects
ES2165768B1 (en) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
US7214687B2 (en) 1999-07-14 2007-05-08 Almirall Ag Quinuclidine derivatives and medicinal compositions containing the same
GB0009583D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
GB0009605D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medicaments
GB0009606D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic combinations
GB0009592D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory combinations
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6787532B2 (en) 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
SK287576B6 (en) 2000-08-05 2011-03-04 Glaxo Group Limited 6Alpha,9alpha-difluoro-17alpha-[(2-furanylcarboxyl)oxy]-11beta- hydroxy-16alpha-methyl-3-oxo-androst-1,4-diene-17beta-carbothioic acid S-fluoromethyl ester as an anti-inflammatory agent, method for the production, farmaceutical composition containing thereof, the use thereof and intermediates
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
OA12403A (en) * 2000-10-12 2006-04-18 Boehringer Ingelheim Pharma Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament.
CN1210017C (en) 2000-10-12 2005-07-13 贝林格尔英格海姆法玛两合公司 Novel tiotropiumonium-containing inhalation powder
BRPI0115076B8 (en) * 2000-10-31 2021-05-25 Boehringer Ingelheim Pharma pharmaceutical preparation, its pharmaceutical application, as well as the process for its preparation
DE10064816A1 (en) * 2000-12-22 2002-06-27 Boehringer Ingelheim Pharma Production of tiotropium bromide useful as an anticholinergic comprises oxidation of di-(2-thienyl)-glycolic acid tropenol ester and subsequent quaternisation
AU2002238471B2 (en) 2000-12-28 2007-06-28 Almirall, S.A. Quinuclidine derivatives and their use as M3 antagonists
US6506900B1 (en) 2001-01-31 2003-01-14 Boehringer Ingelheim Pharma Ag Process for preparing a scopine ester intermediate
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
AR033290A1 (en) 2001-04-30 2003-12-10 Glaxo Group Ltd ANDROSTANO ANTIINFLAMATORY DERIVATIVES
DE10126924A1 (en) * 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalation capsule contains powdered mixture of tiotropium and auxiliary, for treating asthma or chronic obstructive pulmonary disease, having capsule material of low moisture content to improve stability
BR0210537A (en) * 2001-06-22 2004-06-22 Boehringer Ingelheim Pharma Crystalline anticholinergic, process for its preparation and its application for the preparation of a medicine
US6608055B2 (en) 2001-06-22 2003-08-19 Boehringer Ingelheim Pharma Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
US6610849B2 (en) * 2001-06-28 2003-08-26 Boehringer Ingelheim Pharma Kg Process for the manufacture of tropenol
DE10141377A1 (en) 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Scattering process for the production of powder formulations
WO2003035599A1 (en) 2001-10-26 2003-05-01 Pharmacia & Upjohn Company Quarternary ammonium compounds and their use as antimuscarinic agents
DE10200943A1 (en) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Process for the preparation of scopine esters
DE10203749A1 (en) * 2002-01-31 2003-08-14 Boehringer Ingelheim Pharma New anticholinergics, process for their preparation and their use as medicines
US6696462B2 (en) 2002-01-31 2004-02-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
AU2003201745A1 (en) * 2002-02-11 2003-09-04 Pfizer Limited Nicotinamide derivatives and a tiotropium salt in combination for the treatment of e.g. inflammatory, allergic and respiratory diseases
GB0203193D0 (en) * 2002-02-11 2002-03-27 Pfizer Ltd Nicotinamide derivatives useful as pde4 inhibitors
US7309707B2 (en) * 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
DE10212264A1 (en) * 2002-03-20 2003-10-02 Boehringer Ingelheim Pharma Crystalline micronisate, process for its preparation and its use for the manufacture of a medicament
DE10214264A1 (en) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA suspension formulations of an anhydrate
UA80123C2 (en) 2002-04-09 2007-08-27 Boehringer Ingelheim Pharma Inhalation kit comprising inhalable powder of tiotropium
DE10216036A1 (en) 2002-04-11 2003-10-23 Boehringer Ingelheim Pharma Aerosol formulation for inhalation containing a tiotropium salt
DE10224091A1 (en) * 2002-05-31 2003-12-11 Boehringer Ingelheim Pharma Technical process for the production of tropenol
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US7763280B2 (en) 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
CA2513188A1 (en) * 2003-01-16 2004-08-05 University Of Rochester Quaternary antimuscarinic compounds for the treatment of bladder diseases
US20040226556A1 (en) 2003-05-13 2004-11-18 Deem Mark E. Apparatus for treating asthma using neurotoxin
ATE435862T1 (en) 2003-05-28 2009-07-15 Theravance Inc AZABICYCLOALKAN COMPOUNDS AS MUSCARINE RECEPTOR ANTAGONISTS
RS20060291A (en) * 2003-11-03 2008-06-05 Boehringer Ingelheim International Gmbh., Novel crystalline anhydride with anticholinergic effect
PT1682541E (en) 2003-11-03 2010-04-14 Boehringer Ingelheim Int Method for producing tiotropium salts
UY28589A1 (en) * 2003-11-03 2005-06-30 Boehringer Ingelheim Int NEW TIOTROPE SALTS, PROCEDURES FOR PREPARATION, AS WELL AS MEDICINAL FORMULATIONS CONTAINING THEM
US7968717B2 (en) 2003-11-03 2011-06-28 Boehringer Ingelhein International Gmbh Crystalline anhydrate with anticholinergic efficacy
SE0303570L (en) 2003-12-03 2005-06-04 Microdrug Ag Moisture-sensitive medical product
US20080027094A1 (en) * 2004-08-30 2008-01-31 Ono Pharmaceutical Co., Ltd. Tropane Compounds and Pharmaceutical Compositions Comprising the Same as an Active Ingredient
CN101203513A (en) * 2005-05-02 2008-06-18 贝林格尔·英格海姆国际有限公司 Novel crystalline forms of tiotropium bromide
DE102005035112A1 (en) 2005-07-27 2007-02-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg A new process for the preparation of tiotropium salts using N-methylscopinium salts soluble in organic solvents
WO2007017670A1 (en) 2005-08-08 2007-02-15 Argenta Discovery Ltd. Bicyclo[2.2.]hept-7-ylamine derivatives and their uses
TWI389692B (en) 2005-10-10 2013-03-21 Boehringer Ingelheim Int Aerosol formulations for the inhalation of beta-agonists
DE102005059602A1 (en) 2005-12-14 2007-06-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Micronization process
US8163913B2 (en) 2005-12-19 2012-04-24 Sicor Inc. Forms of tiotropium bromide and processes for preparation thereof
US9108962B2 (en) 2005-12-19 2015-08-18 Sicor, Inc. Forms of tiotropium bromide and processes for preparation thereof
US20070167480A1 (en) * 2005-12-19 2007-07-19 Sicor Inc. Pure and stable tiotropium bromide
CN101355937A (en) * 2006-01-04 2009-01-28 贝林格尔·英格海姆国际有限公司 Use of tiotropium salts in the treatment of moderate persistent asthma
ES2298049B1 (en) 2006-07-21 2009-10-20 Laboratorios Almirall S.A. PROCEDURE FOR MANUFACTURING BROMIDE OF 3 (R) - (2-HIDROXI-2,2-DITIEN-2-ILACETOXI) -1- (3-PHENOXIPROPIL) -1-AZONIABICICLO (2.2.2) OCTANO.
DK2046787T3 (en) 2006-08-01 2011-07-18 Glaxo Group Ltd Pyrazolo [3,4-B] pyridine compounds, and their use as PDE4 inhibitors
EP1923393A1 (en) * 2006-11-17 2008-05-21 Boehringer Ingelheim Pharma GmbH & Co. KG Crystalline form of tiotropium bromide and urea
EP1925295A1 (en) * 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Stable powder formulation containing a new antichinolinergic agent
GB0716026D0 (en) 2007-08-16 2007-09-26 Norton Healthcare Ltd An inhalable medicament
CA2608561A1 (en) * 2007-10-29 2009-04-29 Carl Paluszkiewicz Motorcycle wind deflector accessory support
JP6087492B2 (en) * 2008-01-10 2017-03-01 ジェネリクス・[ユーケー]・リミテッド A new process for preparing scopine esters
US8483831B1 (en) 2008-02-15 2013-07-09 Holaira, Inc. System and method for bronchial dilation
EP2100598A1 (en) * 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
AU2009244058B2 (en) 2008-05-09 2015-07-02 Nuvaira, Inc Systems, assemblies, and methods for treating a bronchial tree
EP2172190A1 (en) 2008-10-02 2010-04-07 Laboratorios Liconsa, S.A. Inhalable particles comprising tiotropium
EP2403851B1 (en) 2009-03-06 2015-06-17 Mahmut Bilgic New crystalline forms of tiotropium bromide
CA2763939A1 (en) 2009-05-29 2010-12-02 Pearl Therapeutics, Inc. Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting b2 adrenergic receptor agonists and associated methods and systems
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
WO2011015884A1 (en) 2009-08-07 2011-02-10 Generics [Uk] Limited Process to prepare scopine esters
CA2931876A1 (en) 2009-08-07 2011-02-10 Generics [Uk] Limited Anhydrate of tiotropium bromide
WO2011015883A1 (en) 2009-08-07 2011-02-10 Generics [Uk] Limited Dichloromethane solvate of tiotropium bromide and its use
TR200907237A2 (en) 2009-09-23 2011-04-21 Bi̇lgi̇ç Mahmut Tiotropium dry powder combination
TR200907236A2 (en) 2009-09-23 2011-04-21 Bi̇lgi̇ç Mahmut Transport of Tiotropium dry powder formulation in blister pack.
EP2493408B1 (en) 2009-10-27 2015-06-24 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US8911439B2 (en) 2009-11-11 2014-12-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
AU2010319477A1 (en) 2009-11-11 2012-05-24 Holaira, Inc. Systems, apparatuses, and methods for treating tissue and controlling stenosis
TR200909789A2 (en) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Dry powder combination containing tiotropium, budesonide and a chromoglycic acid derivative combination
TR200909792A2 (en) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Dry powder combination containing tiotropium, corticosteroid and a combination of chromoglycic acid derivative
TR201000679A2 (en) * 2010-01-29 2011-08-22 B�Lg�� Mahmut Dry powder formulations containing a pharmaceutical combination.
TR201000681A2 (en) * 2010-01-29 2011-08-22 B�Lg�� Mahmut Dry powder formulations inhaled.
WO2011093812A2 (en) 2010-01-28 2011-08-04 Mahmut Bilgic Pharmaceutical formulation comprising tiotropium and budesonide in dry powder form
TR200909788A2 (en) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Dry powder formulation suitable for inhalation with tiotropium
TR200909793A2 (en) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Combination of dry powder containing a combination of tiotropium, mometasone and a chromoglycic acid derivative.
TR200909790A2 (en) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Combination of dry powder containing a combination of tiotropium, formoterol and a chromoglycic acid derivative.
WO2011093809A2 (en) 2010-01-28 2011-08-04 Mahmut Bilgic Dry powder pharmaceutical composition comprising tiotropium and ciclesonide
WO2011093810A2 (en) 2010-01-28 2011-08-04 Bilgic Mahmut Dry powder pharmaceutical composition comprising tiotropium and mometasone
US8834931B2 (en) 2009-12-25 2014-09-16 Mahmut Bilgic Dry powder formulation containing tiotropium for inhalation
EP2528600B1 (en) 2010-01-28 2016-06-29 Mahmut Bilgic Dry powder pharmaceutical composition comprising tiotropium and fluticasone
TR201000733A2 (en) 2010-02-02 2011-08-22 Bi̇lgi̇ç Mahmut Pharmaceutical compositions comprising fluticasone, tiotropium and sodium chromoglycate.
TR201002520A2 (en) 2010-04-01 2010-05-21 Bi̇lgi̇ç Mahmut Tiotropium bromide manufacturing method.
TR201005221A2 (en) 2010-04-01 2012-01-23 Bi̇lgi̇ç Mahmut Improved synthesis method.
US8957209B2 (en) 2010-04-01 2015-02-17 Mahmut Bilgic Methods for the synthesis of tiotropium bromide
TR201005222A2 (en) 2010-04-01 2011-10-21 Bi̇lgi̇ç Mahmut Tiotropium bromide synthesis method
TR201007108A2 (en) 2010-08-25 2012-03-21 B�Lg�� Mahmut New tiotropium bromide crystal and production method.
TR201101897A2 (en) 2011-02-28 2012-09-21 Bi̇lgi̇ç Mahmut Crystal material containing tiotropium bromide
TR201111589A2 (en) 2011-03-03 2012-09-21 Bi̇lgi̇ç Mahmut Tiotropium bromide anhydrous crystal form.
TR201102068A2 (en) 2011-03-03 2012-09-21 Bi̇lgi̇ç Mahmut Crystalline substances containing tiotropium bromide
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
ITRM20110508A1 (en) * 2011-09-27 2013-03-28 Lusochimica Spa PROCESS FOR THE PREPARATION OF SCOPINA'S ESTERS.
US8680297B2 (en) 2011-10-06 2014-03-25 Drug Process Licensing Assoc., LLC Manufacturing process for tiotropium bromide
CZ304368B6 (en) 2011-11-28 2014-04-02 Zentiva, K.S. Tiotropium bromide mixed solvate and process for preparing thereof
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
RS55996B1 (en) * 2011-12-22 2017-09-29 Cerbios-Pharma S A Continuous process for the alkylation of cyclic tertiary amines
WO2013109216A2 (en) 2012-01-16 2013-07-25 Mahmut Bilgic Preparation of dry powder formulations comprising tiotropium
CZ201241A3 (en) 2012-01-20 2013-07-31 Zentiva, K.S. Novel polymorphous forms of thiotropium iodide and process for preparing thereof
PT106142B (en) * 2012-02-10 2014-07-18 Hovione Farmaci Ncia S A PROCESS FOR THE PREPARATION OF TIOTROPE BROMIDE
WO2014007773A1 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Compositions comprising muscarinic receptor antagonist and sorbitol
WO2013127738A1 (en) 2012-02-28 2013-09-06 Boehringer Ingelheim International Gmbh Novel propellant-gas-containing tiotropium formulation
CZ304808B6 (en) 2012-03-16 2014-11-05 Zentiva, K.S. Process for preparing scopine ester of di-(2- thienyl)glycolic acid, an intermediate in the synthesis of tiotropium bromide and a new form thereof
CZ305012B6 (en) 2012-03-30 2015-03-25 Zentiva, K.S. Process for preparing scopine ester of di-(2-thienyl)glycolic acid, an intermediate in the synthesis of tiotropium bromide
US10105316B2 (en) 2012-07-05 2018-10-23 Arven llac Sanayi Ve Ticaret A.S. Inhalation compositions comprising muscarinic receptor antagonist
WO2014007769A1 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Compositions comprising muscarinic receptor antagonist and glucose anhydrous
EP2705838A1 (en) 2012-09-06 2014-03-12 Xspray Microparticles Ab Tiotropium preparations
EP2914593B1 (en) 2012-11-05 2017-01-11 Zentiva, k.s. Stabilization of tiotropium solvates
US9398933B2 (en) 2012-12-27 2016-07-26 Holaira, Inc. Methods for improving drug efficacy including a combination of drug administration and nerve modulation
KR102391332B1 (en) 2013-03-15 2022-04-26 펄 테라퓨틱스 인코포레이티드 Methods and systems for conditioning of particulate crystalline materials
AU2014248455B2 (en) 2013-04-01 2018-12-06 Pulmatrix Operating Company, Inc. Tiotropium dry powders
EP2913332A1 (en) * 2014-02-27 2015-09-02 Euticals S.P.A. Crystalline form of tiotropium bromide with lactose
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
US9987260B2 (en) 2015-05-18 2018-06-05 Glenmark Specialty S.A. Tiotropium inhalation solution for nebulization
BR112017020039A2 (en) 2015-05-18 2018-06-05 Glenmark Specialty S.A. pharmaceutical composition, kit, method, process for preparing a pharmaceutical composition and solution
US10653683B2 (en) 2015-05-18 2020-05-19 Glenmark Specialty S.A. Tiotropium inhalation solution for nebulization
KR101748796B1 (en) 2015-09-30 2017-06-19 한미약품 주식회사 Inhalation capsule with enhanced delivery rate of active ingredients
PT3159277T (en) 2015-10-23 2019-09-11 Arven Ilac Sanayi Ve Ticaret As Blister for inhalable formulation of tiotropium bromide
EP3159278A1 (en) 2015-10-23 2017-04-26 Arven Ilac Sanayi Ve Ticaret A.S. Blister for tiotropium bromide inhalable formulation
WO2017138896A1 (en) 2016-02-11 2017-08-17 Sima Patent Ve Lisanslama Hizmetleri Ltd. Şti Crystalline form of tiotropium bromide anhydrate
CN106467535A (en) * 2016-08-28 2017-03-01 杭州百诚医药科技股份有限公司 One kind prepares the purifying process of 2,2 pairs of (2 thienyl) glycolic Rhizoma Scopoliae Japonicae esters
WO2018055642A1 (en) * 2016-09-23 2018-03-29 Gbr Laboratories Pvt. Ltd. A process for preparing tiotropium bromide and intermediates thereof
EA201990605A1 (en) 2016-10-14 2019-10-31 SPRAYED THIOTROPY AND FORMOTEROL COMPOSITIONS
KR102476726B1 (en) 2016-11-16 2022-12-12 글렌마크 스페셜티 에스. 에이. Nebulized Tiotropium
US20200215051A1 (en) 2019-01-03 2020-07-09 Glenmark Specialty S.A. Nebulization composition comprising tiotropium and indacaterol
IL309888A (en) 2021-07-09 2024-03-01 Astrazeneca Pharmaceuticals Lp Compositions, methods and systems for aerosol drug delivery
CN114213408B (en) * 2021-12-15 2023-03-31 台州仙琚药业有限公司 Preparation method of tiotropium bromide
WO2023119093A1 (en) 2021-12-20 2023-06-29 Astrazeneca Ab Compositions, methods and systems for aerosol drug delivery

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB845056A (en) 1957-07-05 1960-08-17 Egyt Gyogyszervegyeszeti Gyar Improvements in or relating to tropane derivatives
DE1166787B (en) * 1960-07-09 1964-04-02 Boehringer & Soehne Gmbh Process for the production of new garnetanol (3ª ‰) esters and their hydrohalides
GB955535A (en) * 1962-10-22 1964-04-15 Boehringer & Soehne Gmbh New n-substituted norgranatanol-(3ª‰)-esters
DE2046659A1 (en) 1970-01-28 1972-03-23
US3808263A (en) * 1970-05-12 1974-04-30 Tanabe Seiyaku Co 6,6-dimethyl-9-alkyl-9-azabicyclo(3.3.1)nonan-3-ols
US3673195A (en) * 1970-05-25 1972-06-27 Tanabe Seiyaku Co Derivatives of 6,6,9-tri-lower alkyl-9-azabicyclo(3.3.1) nonan-3{60 -or 3{62 -ol
US4353922A (en) * 1981-03-13 1982-10-12 Syntex (U.S.A.) Inc. Anticholinergic bronchodilators
DE3546218A1 (en) 1985-12-27 1987-07-02 Madaus & Co Dr AZONIA SPIRONORTROPANOLESTER, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENT
DE3931041C2 (en) 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Esters of thienyl carboxylic acids with amino alcohols, their quaternization products, processes for their preparation and medicaments containing them

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6777423B2 (en) * 2000-10-12 2004-08-17 Boehringer Ingelheim Pharma Kg Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
US6908928B2 (en) * 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
US7244415B2 (en) 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
US7879871B2 (en) 2005-05-02 2011-02-01 Boehringer Ingelheim International Gmbh Crystalline forms of tiotropium bromide

Also Published As

Publication number Publication date
IE65528B1 (en) 1995-11-01
AU642913B2 (en) 1993-11-04
DE3931041A1 (en) 1991-03-28
CZ452390A3 (en) 1998-11-11
SI9011744A (en) 1997-10-31
BG61295B2 (en) 1997-04-30
ES2052125T3 (en) 1994-07-01
YU47800B (en) 1996-01-09
MX9203150A (en) 1992-07-01
YU174490A (en) 1993-10-20
DE10299026I2 (en) 2004-07-01
AU6431890A (en) 1991-04-18
HU9200857D0 (en) 1992-05-28
KR910006272A (en) 1991-04-29
PT95312A (en) 1991-05-22
NL300084I1 (en) 2002-05-01
HU208823B (en) 1994-01-28
IL95691A (en) 1996-07-23
NO921002L (en) 1992-03-13
CA2066248C (en) 1998-08-04
SK279453B6 (en) 1998-11-04
IL95691A0 (en) 1991-06-30
ZA907338B (en) 1992-08-26
SK452390A3 (en) 1998-11-04
NZ235306A (en) 1997-06-24
NO301478B1 (en) 1997-11-03
HRP940723B1 (en) 1999-10-31
PT95312B (en) 1997-06-30
WO1991004252A1 (en) 1991-04-04
HU210612A9 (en) 1995-05-29
RU2073677C1 (en) 1997-02-20
HRP940723A2 (en) 1997-06-30
EP0418716B1 (en) 1994-04-06
FI114395B (en) 2004-10-15
HUT60740A (en) 1992-10-28
EP0418716A1 (en) 1991-03-27
NO921002D0 (en) 1992-03-13
DK0418716T3 (en) 1994-05-02
CA2066248A1 (en) 1991-03-17
USRE39820E1 (en) 2007-09-04
LU90949I2 (en) 2002-10-30
IE903342A1 (en) 1991-04-10
PH31617A (en) 1999-01-12
DE3931041C2 (en) 2000-04-06
NL300084I2 (en) 2002-08-01
NO2002009I2 (en) 2004-10-11
DE59005250D1 (en) 1994-05-11
UA41272C2 (en) 2001-09-17
DE10299026I1 (en) 2002-11-07
FI921087A0 (en) 1992-03-13
JPH05502438A (en) 1993-04-28
DD297647A5 (en) 1992-01-16
KR0168432B1 (en) 1999-01-15
ATE103914T1 (en) 1994-04-15
PL168468B1 (en) 1996-02-29
JPH0730074B2 (en) 1995-04-05
PL286900A1 (en) 1991-12-02
CZ284589B6 (en) 1999-01-13

Similar Documents

Publication Publication Date Title
SI9011744B (en) New esters of carboxylic acid with amino-alcohols, their quaternary products and the preparation and application of these compounds
ATE40368T1 (en) XANTHINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
JPS5569586A (en) 11* 66 and 22substitutedd11carbaa22penenn 33carboxylic acid
RU99104796A (en) THIENOPYRIMIDINES
IE39898L (en) Xanthine derivatives
IE820211L (en) Process for preparing 2-penem compounds
AU538424B2 (en) Piperazino phenylindane
IL62111A (en) Phenylalkenyl imidazole derivatives,their preparation and pharmaceutical compositions containing them
GB1022033A (en) Basic esters
DE69004340T2 (en) Substituted 2-alkynylphenols with anti-inflammatory activity, process for their preparation and pharmaceutical compositions.
ES2000502A6 (en) Poly-4-aminopyrrole-2-carboxamido derivatives and process for their preparation
GB1285400A (en) Esters of substituted anthranilic acid
DE3170937D1 (en) 2-(1,4-benzodioxan-2-ylalkyl) imidazoles, their preparation and pharmaceutical compositions containing them
GB853803A (en) New phenthiazine derivatives and processes for their preparation
ES8200681A1 (en) Process for preparing derivatives of 5,11-dihydro-6h-pyrido[2,3-b][1,4]-benzodiazepin-6-one, and the final derivatives and synthesis intermediates obtained thereby
ES482138A1 (en) Phenylpiperidine derivatives, processes for their preparation and pharmaceutical compositions containing them.
GB1424432A (en) Pharmaceutical compositions
GB1498394A (en) Behenic acid esters of 9-thiaxanthene propylidene heterocyclic alcohols and their use in pharmaceutical composition
ES8200689A1 (en) Acylated cephalosporin analogs, process for their preparation and pharmaceutical compositions comprising them.
AU614589B2 (en) Antiarteriosclerotic agent
DE176049T1 (en) AMINOALKYLNAPHTHALEN DERIVATIVES WITH PHARMACOLOGICAL EFFECT.
YU60790A (en) PROCESS FOR PREPARATION OF 5-PHENYLPYRIMIDINE COMPOUNDS AND THEIR SALTS
NZ218892A (en) Nitrogen-arylmethoxy thiophene derivatives and pharmaceutical compositions
YU46038B (en) PROCEDURE FOR THE PREPARATION OF AZONIASPIRONORTROPANOLESTRES
GB1003645A (en) Indolo-indolizine compounds

Legal Events

Date Code Title Description
IF Valid on the event date